A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.

Stopped The study was terminated as no drug-drug interactions were observed in Part-A of the study and therefore Part-B of the study was not required as per protocol.

Conditions

• Healthy Subjects

Interventions

• DRUG: Nintedanib
• DRUG: AZD5055

Sponsor

AstraZeneca

Collaborators

• [object Object]